Barclays Initiates Coverage On Dorman Products with Overweight Rating, Announces Price Target of $165

Benzinga · 2d ago
Barclays analyst John Babcock initiates coverage on Dorman Products (NASDAQ:DORM) with a Overweight rating and announces Price Target of $165.